Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03764618
Recruitment Status : Recruiting
First Posted : December 5, 2018
Last Update Posted : July 21, 2021
Sponsor:
Information provided by (Responsible Party):
Rigel Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : March 2022